DE69708340T2 - Arylsulfonylimidazolon-derivate als antitumormittel - Google Patents
Arylsulfonylimidazolon-derivate als antitumormittelInfo
- Publication number
- DE69708340T2 DE69708340T2 DE69708340T DE69708340T DE69708340T2 DE 69708340 T2 DE69708340 T2 DE 69708340T2 DE 69708340 T DE69708340 T DE 69708340T DE 69708340 T DE69708340 T DE 69708340T DE 69708340 T2 DE69708340 T2 DE 69708340T2
- Authority
- DE
- Germany
- Prior art keywords
- antituary
- agent
- arylsulfonylimidazolone
- derivatives
- arylsulfonylimidazolone derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940100389 Sulfonylurea Drugs 0.000 abstract 1
- 230000000118 anti-neoplastic effect Effects 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cosmetics (AREA)
- Lubricants (AREA)
- Developing Agents For Electrophotography (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019960034920A KR19980015550A (ko) | 1996-08-22 | 1996-08-22 | 신규한 벤조일로 치환된 인돌린설포닐우레아 유도체 |
KR1019960051939A KR100438482B1 (ko) | 1996-11-05 | 1996-11-05 | 신규한디아릴설포닐이미다졸론유도체 |
KR1019960053450A KR100435085B1 (ko) | 1996-11-12 | 1996-11-12 | 신규설포닐이미다졸론유도체 |
KR1019970019365A KR100437670B1 (ko) | 1997-05-19 | 1997-05-19 | (s)-이성체형태의인돌린설포닐우레아유도체 |
PCT/KR1997/000154 WO1998007719A1 (en) | 1996-08-22 | 1997-08-20 | Arylsulfonylimidazolone derivatives as an antitumor agent |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69708340D1 DE69708340D1 (de) | 2001-12-20 |
DE69708340T2 true DE69708340T2 (de) | 2002-05-16 |
Family
ID=27483149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69708340T Expired - Fee Related DE69708340T2 (de) | 1996-08-22 | 1997-08-20 | Arylsulfonylimidazolon-derivate als antitumormittel |
Country Status (9)
Country | Link |
---|---|
US (2) | US5929103A (de) |
EP (1) | EP1021437B1 (de) |
JP (1) | JP3226100B2 (de) |
CN (1) | CN1079096C (de) |
AT (1) | ATE208774T1 (de) |
AU (1) | AU709107B2 (de) |
CA (1) | CA2263353C (de) |
DE (1) | DE69708340T2 (de) |
WO (1) | WO1998007719A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19919793A1 (de) | 1999-04-30 | 2000-11-02 | Bayer Ag | Neue Sulfonamide |
AU2001256733A1 (en) * | 2000-05-16 | 2001-11-26 | Takeda Chemical Industries Ltd. | Melanin-concentrating hormone antagonist |
KR20030082294A (ko) * | 2002-04-17 | 2003-10-22 | 주식회사 엘지생명과학 | 신규한 아릴설포닐우레아 유도체, 그의 제조방법 및 그를함유하는 항암제 조성물 |
KR20030082292A (ko) * | 2002-04-17 | 2003-10-22 | 주식회사 엘지생명과학 | 신규한 인돌린설포닐우레아 유도체 및 그를 함유하는항암제 조성물 |
US7091232B2 (en) * | 2002-05-21 | 2006-08-15 | Allergan, Inc. | 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
US7358269B2 (en) | 2002-05-21 | 2008-04-15 | Allergan, Inc. | 2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-one |
US7323485B2 (en) | 2002-05-21 | 2008-01-29 | Allergan, Inc. | 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
GB0421525D0 (en) * | 2004-09-28 | 2004-10-27 | Novartis Ag | Inhibitors of protein kineses |
TWI329102B (en) * | 2006-08-15 | 2010-08-21 | Nat Health Research Institutes | Thiourea compounds and method for inhibiting hepatitis c virus infection |
US7985763B2 (en) * | 2007-04-10 | 2011-07-26 | National Health Research Institutes | Hepatitis C virus inhibitors |
WO2008154091A1 (en) * | 2007-06-08 | 2008-12-18 | National Health Research Institutes | Thiourea derivatives |
KR100965247B1 (ko) * | 2008-02-13 | 2010-06-22 | 일동제약주식회사 | 신규한 아릴설포닐이미다졸론 유도체 화합물 및 그화합물을 함유한 항암제 조성물 |
US8198284B2 (en) * | 2008-04-30 | 2012-06-12 | National Health Research Institutes | Treatment of neurodegenerative disorders with thiourea compounds |
KR101458494B1 (ko) * | 2010-07-08 | 2014-11-07 | 충남대학교산학협력단 | 신규한 아릴설포닐이미다졸론 유도체 및 이를 함유하는 항암제 조성물 |
PL231063B1 (pl) | 2013-04-10 | 2019-01-31 | Oncoarendi Therapeutics Spolka Z Ograniczona Odpowiedzialnoscia | Pochodne 1-(podstawionej sulfonylo)-2-aminoimidazoliny jako środki przeciwnowotworowe |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5110830A (en) * | 1984-06-27 | 1992-05-05 | Eli Lilly And Company | Benzenesulfonamides treatment of tumors susceptible to |
US4845128A (en) * | 1984-06-27 | 1989-07-04 | Eli Lilly And Company | N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides |
US5116874A (en) * | 1985-09-23 | 1992-05-26 | Eli Lilly And Company | Anti-tumor method and compounds |
GR862353B (en) * | 1985-09-23 | 1987-01-19 | Lilly Co Eli | Anti-tumor method and compounds |
US4677131A (en) * | 1985-11-01 | 1987-06-30 | Merck & Co., Inc. | Cyclic ureas as dermal penetration enhancers |
JP2764262B2 (ja) * | 1987-08-28 | 1998-06-11 | 持田製薬株式会社 | ヒダントイン誘導体及びそれを有効成分とする医薬組成物 |
WO1990002126A1 (en) * | 1988-08-24 | 1990-03-08 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
IL98784A0 (en) * | 1990-07-17 | 1992-07-15 | Lilly Co Eli | Heterocyclyl sulfonamide derivatives,process for their preparation and pharmaceutical compositions containing them |
US5254582A (en) * | 1992-02-05 | 1993-10-19 | Eli Lilly And Company | Antitumor compositions and methods |
US5169860A (en) * | 1992-03-13 | 1992-12-08 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
CA2110524A1 (en) * | 1992-12-10 | 1994-06-11 | Gerald Burr Grindey | Antitumor compositions and methods of treatment |
US5270329A (en) * | 1992-12-10 | 1993-12-14 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
ZA941500B (en) * | 1993-03-10 | 1995-09-04 | Lilly Co Eli | Antitumor compositions and methods of treatment |
-
1997
- 1997-08-20 CA CA002263353A patent/CA2263353C/en not_active Expired - Fee Related
- 1997-08-20 DE DE69708340T patent/DE69708340T2/de not_active Expired - Fee Related
- 1997-08-20 AT AT97936869T patent/ATE208774T1/de active
- 1997-08-20 AU AU39529/97A patent/AU709107B2/en not_active Ceased
- 1997-08-20 JP JP51060898A patent/JP3226100B2/ja not_active Expired - Fee Related
- 1997-08-20 EP EP97936869A patent/EP1021437B1/de not_active Expired - Lifetime
- 1997-08-20 WO PCT/KR1997/000154 patent/WO1998007719A1/en active IP Right Grant
- 1997-08-20 CN CN97197359A patent/CN1079096C/zh not_active Expired - Fee Related
- 1997-08-21 US US08/915,726 patent/US5929103A/en not_active Expired - Fee Related
-
1998
- 1998-12-16 US US09/212,396 patent/US5932742A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1021437A1 (de) | 2000-07-26 |
WO1998007719A1 (en) | 1998-02-26 |
AU709107B2 (en) | 1999-08-19 |
EP1021437B1 (de) | 2001-11-14 |
CN1079096C (zh) | 2002-02-13 |
US5932742A (en) | 1999-08-03 |
CN1228088A (zh) | 1999-09-08 |
CA2263353C (en) | 2002-04-23 |
DE69708340D1 (de) | 2001-12-20 |
JP2000505096A (ja) | 2000-04-25 |
AU3952997A (en) | 1998-03-06 |
CA2263353A1 (en) | 1998-02-26 |
ATE208774T1 (de) | 2001-11-15 |
US5929103A (en) | 1999-07-27 |
JP3226100B2 (ja) | 2001-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69708340T2 (de) | Arylsulfonylimidazolon-derivate als antitumormittel | |
ATE293618T1 (de) | 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel | |
DE69716135T2 (de) | In 6-position durch thio substituierte paclitaxele | |
NO20013671L (no) | Substituerte bisycliske derivater nyttige som anticancer midler | |
NO20020684L (no) | 3(5)-aminopyrazolderivater, fremgangsmåtet for deres fremstilling og deres anvendelse som antitumormidler | |
HK1088845A1 (en) | Use of parthenolide derivatives as antileukemic and cytotoxic agents | |
ATE315036T1 (de) | 2,4-diaminopyrimidinderivate als immunosuppressiva | |
BR0104350A (pt) | Taxanos de c10 acetato heterossubstituìdo como agentes antitumor | |
HK1078580A1 (en) | Antitumoral analogs of lamellarins | |
TR200403436T2 (tr) | Kristalin 1-metilkarbapenem türevleri. | |
TR200001452T2 (tr) | Bifenilamidin türevleri. | |
DK0842165T3 (da) | Thiazolidin-4-carboxylsyrederivater som cytobeskyttende midler | |
MXPA05005198A (es) | Derivados de imidazoquinolina, como ligandos del receptor a3 de adenosina. | |
CA2356985A1 (en) | 5ht1 antagonists for antidepressant therapy | |
EE200300129A (et) | Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine | |
ES2173586T3 (es) | Derivados de ciclohexandiol. | |
NZ504614A (en) | Echinocandin derivatives and application as anti-fungal agents | |
CO5021190A1 (es) | Agentes terapeuticos | |
ATE250340T1 (de) | 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele | |
ZA200408029B (en) | Novel 1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors. | |
ATE491709T1 (de) | Pyrrolidinohydrochinazoline | |
EA200400764A1 (ru) | 1,3-диарилпроп-2-ен-1-оны, композиция на их основе и применение | |
DK1086695T3 (da) | Antivirale præparater omfattende yohimbin som aktivt princip | |
CA2345724A1 (en) | Use of acylcarnitines as antitumour agents | |
CA2493704A1 (en) | Platinum complexes containing chemically modified bile acids, having antitumor activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |